MedTrace Logo

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

NCT03282474 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-03-08

No results posted yet for this study

Summary

This is a single arm multicenter pilot study to provide preliminary evidence whether sofosbuvir (SOF) is efficacious and can be safely used in patients with chronic Hepatitis E virus infection.

Conditions

  • Hepatitis E
  • Hepatitis Chronic Viral

Interventions

DRUG

Sofosbuvir

Sofosbuvir 400 MG Oral Tablet \[Sovaldi\]

Sponsors & Collaborators

  • HepNet Study House, German Liverfoundation

    collaborator NETWORK

  • Gilead Sciences

    collaborator INDUSTRY

  • German Center for Infection Research

    collaborator OTHER

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Markus Cornberg, Prof. Dr. · Hannover Medical School, Clinic for Gastroenterology, Hepatology, and Endocrinology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-07
Primary Completion
2018-11-26
Completion
2019-02-18

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03282474 on ClinicalTrials.gov